Express Pharma

MARCH 12, 2025

The Indian Pharmaceutical Alliance (IPA) questions the reliance on the US Food and Drug Administration (FDA) Adverse Event Reporting System (FAERS) in the Ohio State University report titled, Are All Generic Drugs Created Equal? An Empirical Analysis of Generic Drug Manufacturing Location and Serious Drug Adverse Events.

Generic Medicine 66

Generic Medicine Process Improvement Dosage Pharmaceutical Manufacturing 66

Quality Matters

JANUARY 23, 2023

Leveraging insights from data on USP standards distribution and usage at more than 22,000 locations worldwide and 40+ external data sets, USP launched the Medicine Supply Map in 2021 to provide an early-warning capability for supply chain vulnerabilities.

Generic Medicine 52

Generic Medicine Pharmaceutical Manufacturing Biosimilars Communication 52

Quality Matters

MAY 18, 2023

Speaking as a fellow panelist at the event, I agreed standardization can have a significant role to play in helping with the regulatory aspects of AMT, particularly when the goal is to advance adoption of such technologies globally. The non-profit maker of essential generic medicines was established by a group of U.S.

Generic Medicine 52

Generic Medicine Pharmaceutical Manufacturing 52

Pharmaceutical Technology

DECEMBER 19, 2022

While the ripple effect of such an event is expected across sectors, in the pharmaceutical arena, small and mid-sized enterprises (SMEs) are predicted to be heavily impacted as the economic downturn affects plans to raise capital, amongst other things. million as part of the Build Back Better Regional Challenge.

Pharmaceutical Companies 69

Pharmaceutical Companies Pharmaceutical Companies Pharmaceutical Manufacturing Generic Medicine 69